Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain.
Botana López M, Camafort Babkowski M, Campuzano Ruiz R, Cebrián Cuenca A, Gargallo Fernández M, David de Paz H, Redondo-Antón J, Artime E, Díaz-Cerezo S, Rubio de Santos M. Botana López M, et al. Among authors: cebrian cuenca a. Adv Ther. 2024 Sep;41(9):3569-3584. doi: 10.1007/s12325-024-02938-2. Epub 2024 Jul 22. Adv Ther. 2024. PMID: 39039388 Free PMC article.
A Retrospective Observational Study Examining the Generalizability of Glucagon-Like Peptide 1 Receptor Agonist Cardiovascular Outcome Trials to the Real-World Population with Type 2 Diabetes in Spain: The REPRESENT Study.
Romera I, Artime E, Ihle K, Díaz-Cerezo S, Rubio de-Santos M, de Prado A, Cebrián-Cuenca A, Conget I. Romera I, et al. Among authors: cebrian cuenca a. Adv Ther. 2022 Aug;39(8):3589-3601. doi: 10.1007/s12325-022-02196-0. Epub 2022 Jun 11. Adv Ther. 2022. PMID: 35689162
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus.
Gorgojo-Martínez JJ, Mezquita-Raya P, Carretero-Gómez J, Castro A, Cebrián-Cuenca A, de Torres-Sánchez A, García-de-Lucas MD, Núñez J, Obaya JC, Soler MJ, Górriz JL, Rubio-Herrera MÁ. Gorgojo-Martínez JJ, et al. Among authors: cebrian cuenca a. J Clin Med. 2022 Dec 24;12(1):145. doi: 10.3390/jcm12010145. J Clin Med. 2022. PMID: 36614945 Free PMC article.
[Cardiovascular preventive recommendations. PAPPS 2020 update].
Orozco-Beltrán D, Brotons Cuixart C, Alemán Sánchez JJ, Banegas Banegas JR, Cebrián-Cuenca AM, Gil Guillen VF, Martín Rioboó E, Navarro Pérez J. Orozco-Beltrán D, et al. Aten Primaria. 2020 Nov;52 Suppl 2(Suppl 2):5-31. doi: 10.1016/j.aprim.2020.08.002. Aten Primaria. 2020. PMID: 33388118 Free PMC article. Spanish.
[Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS].
Orozco-Beltrán D, Brotons Cuixart C, Banegas Banegas JR, Gil Guillén VF, Cebrián Cuenca AM, Martín Rioboó E, Jordá Baldó A, Vicuña J, Navarro Pérez J. Orozco-Beltrán D, et al. Among authors: cebrian cuenca am. Aten Primaria. 2022 Oct;54 Suppl 1(Suppl 1):102444. doi: 10.1016/j.aprim.2022.102444. Aten Primaria. 2022. PMID: 36435583 Free PMC article. Spanish.
Psychometric properties of the Clarke questionnaire for hypoglycemia awareness in the Spanish population with type 2 diabetes.
Orozco-Beltrán D, Lecumberri-Pascual E, Quesada JA, Moreno-Pérez O, Ruiz-Quintero MA, Pomares-Gómez FJ, Jodar-Gimeno E, Pardo-Ruiz C, Mascarell-Martinez I, Mirete-López RM, Morant-Bes B, Borrachero-Guijarro JM, Zapatero-Larrauri M, Aparicio-Egea MC, Paniagua-Merchán C, Requena-Ferrer RM, Caride-Miana E, Fernández-Giménez A, López-Pineda A, Nouni-García R, Carratalá-Munuera C, Cebrián-Cuenca AM. Orozco-Beltrán D, et al. Among authors: cebrian cuenca am. Postgrad Med. 2023 Mar;135(2):141-148. doi: 10.1080/00325481.2022.2138469. Epub 2022 Dec 7. Postgrad Med. 2023. PMID: 36475508
29 results